Humana

HMO Stocks Rise on Medicare Advantage News

Shares of health insurance provider Humana jumped yesterday and are set to gain more today following news that Medicare Advantage might increase reimbursement rates.

Talk of More Corporate Deals Sends Stocks Higher, Dow Above 14,000

Reports that retailers Office Depot and OfficeMax are discussing a merger came after big corporate deals for Heinz and Dell were announced in recent weeks. Some investors are betting that more deals could be on the way as buyers pay premium prices for publicly traded companies.

Report: Premium Hikes for Top Medicare Drug Plans

Millions of seniors enrolled in some of the most popular Medicare prescription drug plans face double-digit premium hikes next year if they don't shop for a better deal, says a private firm that analyzes the highly competitive market.

Health Insurers Post Healthy Profits but Remain Cautious on 2011

The recent pushback on health care reform appears to have boosted the stock prices of health insurance companies, which have outperformed major indexes by quite a margin so far this year. That's because Americans have been cutting back on doctor visits, keeping reimbursement costs low.

Wal-Mart, Humana to Offer Low-Cost Prescription Drug Plan

Wal-Mart Stores (WMT) and Humana (HUM) are teaming up to offer a Medicare prescription drug coverage plan that they say will be the cheapest on the market. Premiums for the Humana Walmart-Preferred Rx Plan will be $14.80 a month, less than half the average premium for Medicare prescription drug plans this year, the companies said in a statement.

Humana Earnings Easily Top Wall Street Estimates

Humana Inc reported diluted earnings per common share of $2 for the second quarter, up from $1.67 in the second quarter of 2009. The earnings easily beat the company%u2019s guidance of $1.65 to $1.70 per share, Humana said in a statement.

Medco's DNA Direct Deal Could Pay Off Big

Medco Health Solutions's purchase of DNA Direct may be small in size but big in potential. It bolsters the pharmacy benefits manager's footprint in personalized medicine, a fast-growing field that uses a patient's genetic data to better target health-care treatments.

Health-Care Sector Appears to Rally As Reform Chances Dim

President Obama can't be pleased by the loss of a Democratic Senate seat which jeopardizes passage of his cherished health-care reform. The news, however, appears to have fueled a mini stock rally in the health-care and pharma sectors wary of how any reform would affect their businesses. The uptrend is expected to continue.